Dr. Reddy's Laboratories Limited has announced that its management will engage with analysts and institutional investors during a conference in London on June 16 and June 17, 2026. The meetings are organized by Investec and will provide a platform for the company to interact with single institutions and investor groups.

The interaction is part of the company's ongoing investor relations activities under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. K Randhir Singh, Company Secretary, Compliance Officer & Head-CSR, signed the intimation on June 10, 2026.

The schedule for the meetings is detailed below:

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors or the Company.

Dr. Reddy's Laboratories Limited has scheduled a series of meetings with analysts and institutional investors on June 9 and June 10, 2026. The company's management will engage with single institutions and investor groups to discuss business performance and strategy. These interactions are part of the company's regular investor relations activities under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The first meeting is organized by ICICI Securities and will take place in Mumbai on June 9, 2026. This will be an in-person group meet scheduled between 10:00 and 17:00 IST. The second engagement is with Macquarie, set to occur in Hyderabad on June 10, 2026. This session is also an in-person group meet, planned for 12:00 to 13:00 IST.

The company noted that the schedule for these meetings is subject to change due to any exigencies on the part of the investors or the company. The intimation was signed by K Randhir Singh, Company Secretary, Compliance Officer & Head-CSR.